Granulomatous Disorders Of Adult Skin An Issue Of Dermatologic Clinics

Granulomatous disorders represent a unique group of diseases both non-infectious and infectious that require the utmost clinical pathologic correlation combined with a keen sense of inquiry for underlying systemic disease. Some of these diseases are common and some are rare; however all dermatologists need to diagnose and manage these diseases whether common or rare. This issue of Dermatology Clinics "Granulomatous Disorders of the Adult Skin" supplies the readers with a comprehensive, up to date, and evidence based review of multiple granulomatous disorders (i.e. palisdaing, epitheliod, xanthomatous, casseating, supprative, vasculitic, lymphoproliferative, foreign body). Dermatologists need to be able to differentiate the entities, evaluate patients for specific underlying systemic diseases (diabetes to cancer) and treat with a wide range of immunosuppressant to anti-infectious agents. This issue will help the dermatologist learn the most current etiopathogenesis, clinical/systemic manifestations and therapeutic modalities for these diseases. Other specialists who would find the information useful: Rheumatologists, Infectious Disease specialists, Hematologists/Oncologists, Endocrinologists, Pulmonologists, Oral-maxillary surgeons, and Pharmacists.

Psoriasis is the most prevalent autoimmune disease in the U.S. • ~125 million people worldwide have psoriasis. Commonly misunderstood and interpreted as a “cosmetic problem, psoriasis is a complex and potentially debilitating disease; nearly 60% of people with psoriasis reported their disease to be a large problem in their everyday life. This issue of Dermatologic Clinics devoted exclusively to psoriasis is edited by two leaders of the International Psoriasis Council, Dr Alan Menter and Dr Chris Griffiths. Topics include: Genetics of psoriasis; Immunopathogenesis of psoriasis; Phenotypical expressions of psoriasis; Psoriasis as a systemic disease with multiple comorbidities; Outcomes measures in the assessment of psoriasis in clinical practice and trials; Update on topical therapies for mild to moderate psoriasis; Phototherapy and photochemotherapy (PUVA) for psoriasis; Current and future oral systemic therapies for psoriasis; Current biological therapies for psoriasis; Future biological therapies for psoriasis; Psoriatic arthritis for the dermatologist; Pharmacogenomics and the future of psoriasis therapies. This information that goes to the heart of clinical practice is equally appropriate, beyond dermatologists, for internal medicine clinicians, primary care physicians, bone & joint specialists; hematologists/oncologists, and researchers in genetic targeted therapy development.

The Editor of this publication is Dr Elise Olsen, Director of the Duke University Cutaneous Lymphoma Research and Treatment Center and professor of Dermatology and Oncology. In 2014, cutaneous lymphoma (CL) is considered a chronic, non-life threatening disease since the majority of patients are diagnosed at early stage, though progression to later stages does result in death from the disease. This issue covers T-cell and B-cell lymphomas, with content emphasis on Mycoides fungoides and Sezary syndrome, the two most common clinically encountered subtypes of CL. Pharmaceutical treatment of the disease is a part of each article and the issue uses the following Treatment outline: Mechanisms of action - Pharmacokinetics - Typical dosing - Response to therapy - Adverse effects - and Pearls to help management using the agent under discussion. Beyond Dermatologists, specialists who would find the information useful are Cancer specialists, Hematologists/Oncologists, Physician Assistants, Nurse Practitioners, and Pharmacists. Some of the topics, written by the word's top experts in this disease, are: Overview of primary cutaneous lymphomas and the applicable staging and classification; Pathologic diagnosis of cutaneous lymphomas; in the section on Mycosis Fungoides and Sezary Syndrome, the clinician and researcher will find such topics as Skin directed medications; Phototherapy; Systemic retinoids; Interferons; HDAC inhibiotrs, Methotrexate and praletexate, along with other chemotherapeutic agents. Also, Bone marrow transplant; Diagnosis and management of CD30+ Lymphoproliferative disorders; and Diagnosis and management of primary cutaneous B cell lymphomas.

Expert on diseases of the nails and also disorders of the nail that indicate systemic disease, Dr Antonella Tosti leads this issue of Dermatologic Clinics. In the article "Tips to Treat 5 Most Common Nail Disorders" readers will find treatment options for brittle nails, onycholysis, paronychia, psoriasis, and onychomycosis, with a practical treatment algorithm. In the article "Tips for Diagnosis and Treatment of Nail Pigmentation" physicians will be able to determine when to wait and see, when to biopsy, and when to excise a pigmented nail lesion. In "Tips to Diagnose Uncommon Nail Disorders" physicians will understand nail disorders that are not very common and should be able to easily diagnose after reading this article. A novel and unique approach in "Tips to Diagnose Nail Diseases from Localization" covers Proximal and lateral nail folds, Nail matrix, and Nail bed/hyponichium. The sectiion on "Tips that Make Nail Surgery Easy" presents practical and simple methods to Obtain a good anesthesia, Perform a punch biopsy; Treat an ingrown toenail, and Best way to remove a subungual tumor; each is accompanied by a technique video. The issue concludes with "Tips to Obtain the Best from your Lab," addressing submitting specimens the right way and using nail clippings for diagnosis beyond fungal diseases; topics are What can be diagnosed with a nail clipping and How to submit a nail specimen.

This most common of all dermatologic conditions seen by dermatologists. What are new developments. What do dermatologists need to best treat their patients? In this issue of Dermatologic Clinics, expert practitioners and academics, Dr. James Del Rosso and Dr. Joshua Zeichner lead distinguished clinicians in presenting such topics as: How the Internet and Social Media Have Changed the Management of Acne; Evaluation of Acne Scars: How to Assess Them and What To Tell The Patient; Pathophysiology of Acne; The Role of Skin Care in the Management of Acne Vulgaris; Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris; Use of Oral Contraceptives for Acne Vulgaris: Practical Considerations in Real World Practice; Use of Antibiotics in Acne: Achieving Optimal Outcomes While Maintaining Antibiotic Stewardship; Status Report on Oral Isotretinoin: Has Anything Changed That Is Relevant to Clinicians?; Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne; Evaluation and Management of Refractory Acne Vulgaris in Adolescent and Adult Men; Physical Modalities in the Management of Acne; 12. Cases of "Acne" That Turned Out To Not Be Acne.

This issue of Immunology and Allergy Clinics, guest edited by Drs. Peck Ong and Peter Schmid-Grendelmeier, is devoted to Allergic Skin Diseases. Articles in this issue include Wet-wrap Therapy in Atopic Dermatitis; Biologics in Chronic Urticaria; Clinical Measures of Chronic Urticaria; Cutaneous Manifestation of Drug Allergy; Itch in Atopic Dermatitis; Biomarkers in Atopic Dermatitis; Differential Diagnosis of Atopic Dermatitis; Differential Diagnosis of Chronic Urticaria; ACE-inhibitor-induced Angioedema; The Role of Fungi in Atopic Dermatitis; Cutaneous Manifestation of Food Allergy; Pediatric Mastocytosis; Allergic Contact Dermatitis; Hereditary Angioedema; Infectious Complications in Atopic Dermatitis; and Cutaneous Manifestations Primary Immunodeficiency/Autoimmunity.

Topics in this issue of Dermatologic Clinics include: Incidence and prevalence; Impact on quality of life; Special considerations of hyperhidrosis in children; Topical therapies; Iontophoresis; Botox for axillary hyperhidrosis; Botox for palmar/plantar hyperhidrosis; Botox for other hyperhidrosis; Systemic therapies for hyperhidrosis; Procedural approaches; Endoscopic thoracic sympathectomy; Emerging and investigative treatments; Resources for patients and physicians; Incorporating diagnosis and treatment into clinical practice. Dr David Pariser is Editor of this publication; a founding member of the International Hyperhidrosis Society and renown researcher and lecturer on mechanism, diagnosis, and treatment of hyperhidrosis, Dr Pariser continues to investigate therapies that are effective for patients.

The painful and often scarring disease hidradenitis suppurtiva is presented comprehensively in this issue of Dermatologic Clinics led by expert Gregor Borut Ernst Jemec. Topics include: Diagnosing hidradentis suppurativa; Prevalence, risk factors and co-morbidities of hidradentis suppurativa; Genetics of hidradentis suppurativa; Histopathology and imaging; Inflammatory mechanisms in hidradentis suppurativa; Microbiology of hidradentis suppurativa; Endocrinological aspects of hidradentis suppurativa; Role of mechanical stress in hidradenitis suppurativa; Randomized controlled trials of hidradentis suppurativa treatment; Antibiotic treatment of hidradentis suppurativa; Other medical treatments of hidradentis suppurativa; Surgical interventions in hidradentis suppurativa; Lasers and IPL in hidradenitis suppurativa; The Handicap of hidradentis suppurativa.